Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Getting stupider every day...
View:
Post by sunshine7 on Jul 13, 2016 1:58pm

Getting stupider every day...

2016 Guidance at over $9CD and recent company statements are "AMCo performing to expectations" and "currency fluctuations due to Brexit have no significant mid term effect on earnings due to natural hedges in place". 2016 guidance did not include the recently acquired 4 products. 2017 forecast is for ~10% growth. OK, that one may take a hit, but still trading at under 3x(adj)eps. Why?
Comment by fdfd12 on Jul 13, 2016 2:36pm
Sunny when this happens (stock just goes down and not where it should go), that means a BIG negative surprise will be unveiled. Either lower guidance to be announced, or some drug gouging problem etc... Let's hope not.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities